Literature DB >> 29725907

Genetic Factors Associated with Postoperative Nausea and Vomiting: a Systematic Review.

Pedro López-Morales1,2, Diego Flores-Funes3,4,5,6, Elena González Sánchez-Migallón1,2,7, Ramón José Lirón-Ruiz1,2,7, José Luis Aguayo-Albasini1,2,8.   

Abstract

BACKGROUND: In previous studies, there seems to be a relationship between different genetic polymorphisms and postoperative nausea and vomiting (PONV). We perform a systematic review of the current literature about the relationship between genetic polymorphisms and the presence of PONV.
METHODS: Two bibliographic searches were carried out in three databases (PubMed, Web of Science, and Scopus) of studies, preferably prospective, about PONV following abdominal surgery. It was completed with a backward citation searching. A total of 73 articles were found of which 6 were selected after their critical lecture using CASPe network criteria. Relative frequency and relative risk were taken in each study according to the polymorphism.
RESULTS: Studies about 5-HT3B gene receptor polymorphisms, ABCB1 transporter, and dopamine D2 receptor showed a significant association with the presence of PONV (p = 0.02, 0.01, and 0.034 respectively). In relation to cytochrome P-450 2D6 (CYP2D6) polymorphisms, two of the three analysed articles showed a significant association with postoperative vomiting (p = 0.007).
CONCLUSION: Genetic polymorphisms could play an important role in PONV. The AAG deletion in both alleles of the 5-HT3B receptor gene, the Taq IA polymorphism of the dopamine D2 receptor, and the presence of three or more functional alleles of CYP2D6 seem to be related with a higher incidence of PONV, especially in the first 24 h after surgery. The 2677TT and 3435TT genotypes of the ABCB1 transporter could reduce the PONV due to their association with a greater effectiveness of ondansetron. However, new quality studies are needed to consider this relationship.

Entities:  

Keywords:  Genetic polymorphism; Ondansetron; Postoperative nausea and vomiting; Risk factor; Ultrarapid metaboliser

Mesh:

Substances:

Year:  2018        PMID: 29725907     DOI: 10.1007/s11605-018-3788-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  25 in total

1.  Association of the ABCB1 3435C>T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists.

Authors:  Melih O Babaoglu; Banu Bayar; A Sukru Aynacioglu; Reinhold Kerb; Huseyin Abali; Ismail Celik; Atila Bozkurt
Journal:  Clin Pharmacol Ther       Date:  2005-12       Impact factor: 6.875

2.  The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.

Authors:  Jürgen Brockmöller; Julia Kirchheiner; Jürgen Schmider; Silke Walter; Christoph Sachse; Bruno Müller-Oerlinghausen; Ivar Roots
Journal:  Clin Pharmacol Ther       Date:  2002-10       Impact factor: 6.875

3.  The impact of pharmacogenomics on postoperative nausea and vomiting: do CYP2D6 allele copy number and polymorphisms affect the success or failure of ondansetron prophylaxis?

Authors:  Keith A Candiotti; David J Birnbach; David A Lubarsky; Fani Nhuch; Aimee Kamat; Walter H Koch; Michele Nikoloff; Lin Wu; David Andrews
Journal:  Anesthesiology       Date:  2005-03       Impact factor: 7.892

Review 4.  Cytochrome P450 2D6 metabolism and 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.

Authors:  Piotr K Janicki
Journal:  Med Sci Monit       Date:  2005-09-26

5.  The association of CYP2D6 genotype and postoperative nausea and vomiting in orthopedic trauma patients.

Authors:  Susan W Wesmiller; Richard A Henker; Susan M Sereika; Heidi S Donovan; Li Meng; Gary S Gruen; Ivan S Tarkin; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2012-06-20       Impact factor: 2.522

6.  Codeine intoxication associated with ultrarapid CYP2D6 metabolism.

Authors:  Yvan Gasche; Youssef Daali; Marc Fathi; Alberto Chiappe; Silvia Cottini; Pierre Dayer; Jules Desmeules
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

7.  P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.

Authors:  A H Schinkel; E Wagenaar; C A Mol; L van Deemter
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

8.  Increased incidence of CYP2D6 gene duplication in patients with persistent mood disorders: ultrarapid metabolism of antidepressants as a cause of nonresponse. A pilot study.

Authors:  Chiaki Kawanishi; Stefan Lundgren; Hans Agren; Leif Bertilsson
Journal:  Eur J Clin Pharmacol       Date:  2003-12-02       Impact factor: 2.953

9.  Effect of CYP3A4*18B polymorphisms and interactions with OPRM1 A118G on postoperative fentanyl requirements in patients undergoing radical gastrectomy.

Authors:  Qin Liao; Dao-Jin Chen; Fan Zhang; Li Li; Rong Hu; Yong-Zhong Tang; Wen Ou-Yang; Dong Huang
Journal:  Mol Med Rep       Date:  2013-01-11       Impact factor: 2.952

10.  Prevention of postoperative nausea and vomiting with granisetron and dolasetron in relation to CYP2D6 genotype.

Authors:  Piotr K Janicki; H Gregg Schuler; Tomasz M Jarzembowski; Malina Rossi
Journal:  Anesth Analg       Date:  2006-04       Impact factor: 5.108

View more
  2 in total

1.  Pharmacogenetic and clinical predictors of ondansetron failure in a diverse pediatric oncology population.

Authors:  Shana S Jacobs; Jeffrey S Dome; Jiaxiang Gai; Andrea M Gross; Elena Postell; Pamela S Hinds; Lionel Davenport; John N van den Anker; Catriona Mowbray
Journal:  Support Care Cancer       Date:  2022-01-11       Impact factor: 3.603

2.  CHRM3 rs2165870 Polymorphism Correlates with Postoperative Nausea and Vomiting Incidence and the Efficacy of Ondansetron in a Chinese Han Population.

Authors:  Jiayu Wang; Yang Li; Cuijuan Zheng; Yan Sun; Jianping Yang
Journal:  Pharmgenomics Pers Med       Date:  2020-08-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.